Bruker Corp. (NASDAQ:BRKR) has received a consensus recommendation of “Hold” from the twenty-one analysts that are covering the company. One research analyst has rated the stock with a sell rating, twelve have given a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $25.67.

BRKR has been the subject of several research analyst reports. Cantor Fitzgerald reduced their price objective on Bruker Corp. from $34.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 3rd. Janney Montgomery Scott upgraded Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 price objective for the company in a report on Wednesday, August 3rd. Zacks Investment Research upgraded Bruker Corp. from a “hold” rating to a “buy” rating and set a $25.00 price objective for the company in a report on Wednesday, June 29th. Morgan Stanley set a $23.00 price objective on Bruker Corp. and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Finally, Wells Fargo & Co. downgraded Bruker Corp. from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 3rd.

In other Bruker Corp. news, Director Richard A. Packer bought 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 10th. The shares were bought at an average price of $21.97 per share, with a total value of $219,700.00. Following the purchase, the director now owns 22,500 shares of the company’s stock, valued at $494,325. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Frank H. Laukien bought 4,500 shares of the firm’s stock in a transaction that occurred on Friday, August 5th. The shares were acquired at an average cost of $22.17 per share, for a total transaction of $99,765.00. Following the purchase, the chief executive officer now directly owns 37,658,733 shares in the company, valued at approximately $834,894,110.61. The disclosure for this purchase can be found here. Corporate insiders own 35.80% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada increased its stake in Bruker Corp. by 104.3% in the second quarter. Royal Bank of Canada now owns 49,186 shares of the company’s stock worth $1,119,000 after buying an additional 25,113 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in Bruker Corp. by 14.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 454,720 shares of the company’s stock worth $10,341,000 after buying an additional 58,920 shares during the last quarter. Amalgamated Bank increased its stake in Bruker Corp. by 27.0% in the second quarter. Amalgamated Bank now owns 16,688 shares of the company’s stock worth $373,000 after buying an additional 3,552 shares during the last quarter. Legal & General Group Plc increased its stake in Bruker Corp. by 4.1% in the second quarter. Legal & General Group Plc now owns 8,460 shares of the company’s stock worth $192,000 after buying an additional 335 shares during the last quarter. Finally, Numeric Investors LLC purchased a new stake in Bruker Corp. during the second quarter worth about $1,207,000. 69.92% of the stock is currently owned by institutional investors and hedge funds.

Shares of Bruker Corp. (NASDAQ:BRKR) traded down 0.18% during midday trading on Monday, hitting $22.35. The stock had a trading volume of 156,819 shares. Bruker Corp. has a 12 month low of $16.61 and a 12 month high of $29.85. The stock’s 50 day moving average price is $22.30 and its 200 day moving average price is $24.87. The firm has a market cap of $3.60 billion, a price-to-earnings ratio of 33.66 and a beta of 0.93.

Bruker Corp. (NASDAQ:BRKR) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. Bruker Corp. had a return on equity of 22.66% and a net margin of 6.86%. The company earned $371.70 million during the quarter, compared to the consensus estimate of $409.57 million. During the same period last year, the company earned $0.19 EPS. Bruker Corp.’s revenue for the quarter was down 6.1% on a year-over-year basis. On average, equities analysts forecast that Bruker Corp. will post $1.00 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Tuesday, September 6th were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.72%. The ex-dividend date was Thursday, September 1st. Bruker Corp.’s dividend payout ratio (DPR) is presently 24.24%.

Bruker Corp. Company Profile

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Receive News & Stock Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related stocks with our FREE daily email newsletter.